Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women.
Strandberg
Timo E
TE
Department of Medicine, Geriatric Clinic, University of Helsinki, PO Box 340, FIN-00029 HUS, Finland. timo.strandberg@hus.fi
Ylikorkala
Olavi
O
Tikkanen
Matti J
MJ
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000367:Age Factors; D001786:Blood Glucose / Q000032:analysis* / Q000187:drug effects*; D002097:C-Reactive Protein / Q000032:analysis* / Q000187:drug effects*; D002318:Cardiovascular Diseases / Q000097:blood* / Q000517:prevention & control*; D003277:Contraceptives, Oral, Combined / Q000008:administration & dosage* / Q000494:pharmacology* / Q000627:therapeutic use; D004338:Drug Combinations; D004958:Estradiol / Q000008:administration & dosage* / Q000494:pharmacology* / Q000627:therapeutic use; D004964:Estriol / Q000008:administration & dosage* / Q000494:pharmacology* / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000097:blood*; D007328:Insulin / Q000097:blood*; D008055:Lipids / Q000097:blood*; D008875:Middle Aged; D009640:Norethindrone / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000494:pharmacology* / Q000627:therapeutic use; D012016:Reference Values; D012307:Risk Factors
D001786:Blood Glucose; D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D007004:Hypoglycemic Agents; D007328:Insulin; D008055:Lipids; C418365:estradiol, norethindrone drug combination; D004958:Estradiol; C038117:netagen; C032040:Trisequens; D002097:C-Reactive Protein; D004964:Estriol; D009640:Norethindrone